KINDLER JEFFREY B sold $1.4M of PGEN
KINDLER JEFFREY B sold 185,000 shares of PRECIGEN, INC. (PGEN) at $7.44 ($1.38M total) on 2026-08-26.
How this was made
The 30-second read
Why it matters
The sale represents a modest reduction in insider ownership, likely exerting limited price impact.
Market read
Insider sale of $1.4M by a director may cause slight short-term price pressure but is not a major catalyst.
What to watch
No accompanying news on company performance or upcoming events to contextualize the sale.
Background
Form 4 filings disclose insider transactions; director sales are monitored by traders for signals.
Ticker impact
Director Jeffrey Kindler sold 185,000 shares for $1.376M on 2026-08-26, reducing his stake to 17,100 shares.
Slight downward pressure in short term.
Insider sales by a director can be interpreted as lack of confidence, but the amount is modest relative to market cap.
Market effects
Minimal impact on biotech sector; similar insider sales are common.
None
None
Counterpoint
The sale may be unrelated to company outlook; could be personal liquidity need.
Key entities
- CompanyPrecigen, Inc.
Biotech firm listed on NASDAQ under ticker PGEN.
- IndividualJeffrey B. Kindler
Director of Precigen, Inc.
